Fund Holdings — BML Capital Management, LLC

Total Portfolio Value
$155.44M
Total Bought
$19.20M
Total Sold
$11.37M
Net Transaction
+$7.83M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
ATEA PHARMACEUTICALS INC(AVIR)7,490,0007,058,657-431,34326,73937,97624.43%+11,236
ACLARIS THERAPEUTICS INC(ACRS)14,250,00014,250,000042,89353,43834.38%+10,545
TILLYS INC(TLYS)02,150,000+2,150,00008,7085.60%+8,708
OUTSET MED INC(OM)543,1801,902,201+1,359,0212,0157,3044.70%+5,289
KRAFT HEINZ CO(KHC)0125,000+125,00002,8111.81%+2,811
JANUX THERAPEUTICS INC(JANX)0154,961+154,96102,1541.39%+2,154
ORAMED PHARMACEUTICALS INC(ORMP)3,167,2313,167,23109,02710,7696.93%+1,742
TARGET CORP(TGT)37,50037,50003,6664,5452.92%+879
KEZAR LIFE SCIENCES INC
COM NEW
720,787720,78704,5345,3483.44%+814
CARMAX INC(KMX)155,000155,00005,9896,4454.15%+456
PLIANT THERAPEUTICS INC(PLRX)1,546,1371,546,13701,8861,9481.25%+62
PMV PHARMACEUTICALS INC(PMVP)5,292,0005,320,000+28,0006,6156,5974.24%-18
CONNECT BIOPHARMA HLDGS LTD(CNTB)408,887408,88701,1531,0710.69%-82
LISATA THERAPEUTICS INC(LSTA)73,3480-73,3481360—-136
IMAGENEBIO INC(IMA)177,026200,730+23,7041,2211,0040.65%-218
INSTIL BIO INC(TIL)645,600645,60007,1025,3203.42%-1,782
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q1 2026 | TickerTrail